IONS
Ionis Pharmaceuticals, Inc.
Halal Rating :
See Details
Last Price
$43.67
Last updated:
Market Cap
$6.5b
7D Change
1.85%
1 Year Change
-1.76%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 8, 2023
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $186.12m | $46.14m | - | $2.29m | 0.00% | 4.97% |
| March 31, 2023 | $128.39m | $46.57m | - | $1.61m | 0.00% | 3.45% |
| Dec. 31, 2022 | $151.89m | $150.1m | - | $1.73m | 0.00% | 1.15% |
Company Impact
Help us evaluate Ionis Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.